ABSTRACT
3
The use of caffeine in preterm infants continues to be an exciting and controversial area of caffeine is able to drive lung alveolarization, or protect the developing lung from injurious 76 insults, remains a matter of debate (32).
77
BPD results from a combination of oxygen toxicity, inflammation, and mechanical 78 stress during respiratory support of affected patients (19). These same injurious stimuli are 79 employed to model BPD in experimental animals (2, 24), including mice (5, 25), rats (27), 80 rabbits (9), pigs (4, 6), lambs (1), and non-human primates (39). At this junction, it is 81 important to recognize the limitation of term animal -particularly rodent -BPD models. The 82 primary utility of caffeine in a neonatal intensive care setting is to reduce apnea, which 4 reduces the need for mechanical ventilation and oxygen supplementation, by stimulating 84 respiratory efforts. As there is no apnea is mouse pups exposed to hyperoxia, the impact of 85 caffeine on this very important aspect of the clinical consequences of preterm birth is never 86 addressed in animal models (2, 24), even though caffeine also increases the respiratory rate in 87 mouse pups (28). The discussion that follows here is restricted exclusively to the more 88 controversial question of whether, as a side-effect of the use of caffeine to manage apnea, The report of Teng and co-workers is interesting, given the observations that both 146 COX-2 and the ER stress/UPR pathways are activated in the lungs of pre-term infants with 147 BPD (7). In pioneering work from the Bhandari laboratory, COX-2 inhibition, using The study of Teng and co-workers is limited in that the study reported two separate 155 sets of observations in parallel, but did not functionally connect the two arms of the study. To the latter point, a vast number of effects of caffeine on the lung have been co-workers to demonstrate that the protective effects of caffeine administration in rats is due holds true for studies in non-human primates and rabbits (Fig. 1, blue routes) . In contrast, all 189 caffeine administration studies undertaken in mouse models of BPD have failed to 190 demonstrate any protective effects of caffeine (Fig. 1, red routes) : in one study, caffeine 
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